Radiation therapy: state of the art and the future by Ikushima, Hitoshi
INTRODUCTION
The number of patients treated with radiation
therapy (RT) is rapidly increasing due to the spread
of high-precision RT and diagnostic imaging sys-
tems, which facilitate low invasiveness in the treat-
ment of cancer. Technical innovation of irradiation
has made it possible to target high radiation doses
to the lesion with great accuracy, resulting in high
tumor control rates and making RT an alternative
to surgery for various cancers. In this paper the
course of development of present and future irra-
diation techniques are discussed, and the role of
RT as the current standard treatment for cancer is
reviewed.
FROM TWO-DIMENSIONAL RADIATION
THERAPY TO THREE- AND FOUR- DI-
MENSIONAL RADIATION THERAPY
Conformal radiation delivery technique
The dose-effect relationship in both tumor and
normal tissue is characterized by a sigmoid curve,
as shown in the Figure 1. The cure probability of RT
depends on the difference between tumor cell kill
and the development of normal tissue toxicity due
to radiation. A radiation dose which can maximize
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the difference between tumor and normal tissue
damage represents the optimal dose for the patient.
If we can reduce the radiation dose to the surround-
ing normal tissues adjacent to the tumor, by improv-
ing dose conformity, the sigmoid curve for normal
tissue damage can be shifted to a higher dose area.
This makes it possible to escalate the tumor dose,
resulting in an improvement in the cure rate. Cur-
rently, radiation delivery techniques are primarily
centered on external beam RT and brachytherapy.
Technical innovation of both of these techniques
always aims to improve dose distribution conformity
with the objective of decreasing normal tissue tox-
icity. The precision of external beam RT, which is
the main delivery method for high-energy ionizing
radiation to lesions from outside of the body, has
been markedly improved by innovative technical de-
velopment of various imaging modalities and irra-
diation devices. Formerly, the irradiation field was
defined two- dimensionally by referring to bony
structures on X-ray films. However, the first step
in current RT planning is the definition of the tar-
get volume, which has been internationally defined
by the International Commission of Radiation Units
and measurements (ICRU) Report 62 (1) (Fig. 2). In
the concrete process of RT planning, the contours
of the target and organ at risk (OAR) are deline-
ated on the RT planning system (RTPS) using data
Figure 1. Dose effects on tumor and normal tissue
A radiation dose which can maximize the difference between tumor and normal tissue damage represents the optimal dose for the
patient in radiation therapy, and a cure rate becomes greatest with the optimal dose. If normal tissue toxicity curve can be shifted to
higher dose area by innovative technical development of irradiation, a cure rate improves (arrows).
Figure 2. Target definition by ICRU Report 62 (1) in radiation
therapy
Gross tumor volume (GTV) : tumor volume obviously delineated
on imaging, Clinical target volume (CTV) : target volume includ-
ing subclinical tumor extension, Internal target volume (ITV) :
target volume including internal movement of tumor, Planning
target volume (PTV) : target volume including set-up margin
around ITV
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on anatomical position and X-ray transmittance de-
rived from CT. In the next step the setting of a num-
ber of beams, their angle and relative dose alloca-
tion is performed, and finally the absorption dose
for the target and OAR is calculated. Biology-based
planning using functional imaging, such as magnetic
resonance imaging and positron emission tomogra-
phy, is used according to necessity. A multi-leaf col-
limator (MLC) located at the nozzle of the external
beam RT device is online with RTPS. Three- dimen-
sionally conformed irradiation of the target becomes
possible due to MLC formatting of irradiation ac-
cording to the shape of the target in each beam. The
final irradiation method is determined after evalu-
ation of the dose distribution chart and dose volume
histogram of the target, and all OAR in the patient
body. A three-dimensional RT planning image for
uterine cervical cancer is showed in Figure 3.
Every organ in the human body has internal
movement (IM), and thus the target of the RT is
also moving and changing its shape during irradia-
tion. A new concept of internal target volume (ITV)
is advocated as a volume to compensate for IM in
ICRU report 62. Lung cancer that develops in the or-
gan with the largest IM shows respiratory motion of
up to 2 cm (2). Four-dimensional CT (4DCT) was
developed as a new technology to define the ITV of
the tumor in the lungs and liver, organs that both
have large IMs. In 4DCT, anterior abdominal mo-
tion is monitored as a surrogate of respiratory mo-
tion during CT scanning. All CT data has informa-
tion on the respiratory phase derived from simul-
taneously monitored respiratory motion (Fig. 4a).
CT images are all sorted according to the 10 bines
corresponding to the 10 phases of the full breath-
ing cycle, and these images include information on
(a)
(b)
Figure 3. 3 dimensional radiation therapy planning for uterine cervical cancer with paraaortic lymph nodes metastases
(a) Contours of target (red line : primary lesion and regional lymph nodes metastases) and organ at risks (yellow line : urinary blad-
der, blue line : right ureter) are delineated on CT images. (b) Radiation field formed by multi - leaf collimator on a digitally recon-
structed CT image.
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the position and shape of the target in all respira-
tory phases. A contour of the ITV is defined on
maximum intensity projection images to clearly de-
lineate its border. (Fig. 4d) Dose calculation is per-
formed using phase average CT, whose density is
adjusted depending on the real speed of tumor mo-
tion (Fig. 4c). Radiation therapy that is planned,
based on such an ITV defined on 4DCT, can cover
the target’s motion over the treatment time and is
thus termed four-dimensional RT (4DRT). Inter-
cepting radiation that can irradiate a target at any
given position during respiratory motion is one of
treatment methods that falls into the category of
4DRT. Intercepting RT can reduce the ITV by re-
ducing IM, resulting in a dose reduction to the
OAR. Also, there is a new concept in dealing with
target movement known as chasing RT. This mo-
dality can irradiate a target while chasing it. Com-
puter software supporting chasing irradiation tech-
nology is under development.
Stereotactic irradiation
Stereotactic irradiation (STI) is a highly precise
treatment method that focuses a narrow ionizing ra-
diation beam on the target from various directions.
STI involves the use of an immobilization system
(a)
(b) (c) (d)
Figure 4. Respiratory motion tracking with retrospective gating
(a) Information on respiratory phase is attached to computed tomography (CT) images by performing CT scan simultaneously monitoring
respiratory motion of the target during one respiratory cycle. All CT images are sorted according to 10 bines corresponding to 10
phases of the full breathing cycle for radiation therapy treatment planning. (b) A reconstructed sagittal plane image derived from
fast spiral CT under free breathing : This image can show the target only at a point of time in respiratory phase. (c) A reconstructed
sagittal plane image derived from 4 dimensional CT (4DCT) based phase average CT (d) Internal target volume definition on a re-
constructed sagittal plane image of 4DCT based maximum intensity projection (red line : gross tumor volume (GTV) in 10 respira-
tory phases, yellow line : ITV defined by adding subclinical tumor extension around GTV, blue line : planning target volume defined
by adding set-up margin around ITV)
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that can minimize isocenter deviation in the patient’s
body, or a coordinate system fixed to the patient,
to within2 mm in a treatment for brain tumors and
to within5 mm for the treatment of tumors located
in other body organs (Fig. 5). If a target volume is
small, STI enables the delivery of a large dose of
radiation to the target in a single fraction or a small
number of fractionations, resulting in an enhanced
antitumor effect. The main target for STI is the me-
tastatic brain tumor, because it can be clearly de-
fined on imaging systems and the majority of these
tumors are detected when they are small. However,
since 2004 insurance policies have started to cover
solitary lung cancer and liver tumors with a diame-
ter of less than 5 cm for STI treatment. STI is clas-
sified as stereotactic radiosurgery (SRS) that can
complete a treatment using a single fraction, and
stereotactic RT (SRT) that can deliver radiation in
a number of fractions. Dose fractionation increases
the total radiation dose that normal tissues can tol-
erate before developing late radiation morbidity.
Therefore, SRT seems to be superior to SRS, at least
in theory. However, the fractionation method has
not yet been standardized due to some practical dif-
ficulties such as responsibility of staffs. The stan-
dardization of an appropriate fractionation schedule
for SRT has not presently been achieved.
Intensity modulated radiation therapy
Intensity modulated RT (IMRT) is an emerging
irradiation technique that has achieved a marked
improvement in three-dimensional dose conver-
gence on a target, by modulation of the beam in-
tensity distribution within a field. IMRT can deliver a
(a) (b)
(c) (d)
Figure 5. Stereotactic irradiation
(a) Tracks of radiation beams in small volume multiple arcs radiation therapy (SMART) using linear accelerator for brain tumor
(b) Dose distribution demonstrated on a CT axial image in SMART for metastatic brain tumor.
(c) Beam arrangement in non-coplanar static multiple portals irradiation for lung cancer
(d) Dose distribution demonstrated on a coronal CT image in stereotactic radiation therapy for lung cancer
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higher radiation dose to a target while reducing the
dose to the surrounding normal tissue (3-6). This
modality can produce a horseshoe shaped dose dis-
tribution and it is useful, especially in head and neck
tumors and prostate cancer, whose target is always
abutting on OAR (Fig. 6). In IMRT, optimal intensity
modulation is produced by continuous irradiation
using various irregular fields with the MLC configu-
ration being based on intensity maps calculated
using RTPS. A newly developed technology in the
field of IMRT, known as volumetric modulated arc
therapy (VMAT), has been predicted to become
widely deployed in Japan. In VMAT, modulation of
beam intensity is achieved by regulating the dose-
rate and the MLC dynamically with a rotating gan-
try in a linear accelerator. VMAT requires shorter
treatment time than conventional IMRT, and can be
completed within approximately 1.5 min. Shorten-
ing the treatment time makes it possible to reduce
the effect of target deviation during a treatment, and
results in improvement in the accuracy of irradia-
tion and a reduction in the low-dose radiation expo-
sure to patients. Moreover, the primary advantage
of VMAT in the clinic is its ability to increase treat-
ment throughput, which is a very important con-
sideration given the expected increase in patients.
(a)
(b)
Figure 6. Intensity modulated radiation therapy
(a) A case of head and neck tumor treated by intensity modulated radiation therapy (IMRT) with 9 beams (cited from reference 7),
Intensity modulation shown on a figure is performed in every beam. (b) Dose distribution chart on an axial image of CT in IMRT
(green : cross section of the spinal cord, orange : cross section of the salivary glands), IMRT realize conformal dose distribution to
the target, and irradiated dose to the adjacent normal tissue can be reduced. IMRT becomes an effective irradiation method for the
patients where the organs at risk such as spinal cord and salivary glands locate beside the target.
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Image-guided radiation therapy
High precision RT, such as IMRT, that can de-
liver a three dimensionally conformed dose distri-
bution to a target shape requires a higher level of
irradiation accuracy. In IMRT, even a tiny deviation
in the target position can cause serious target dose
deficiency, in terms of tumor control. Image-guided
radiation therapy (IGRT) is a technology that was
introduced to obtain higher precision irradiation.
In RT planning, the planning target volume (PTV)
is created by adding the necessary three- dimen-
sional safety margins to the clinical target volume
(CTV) to deliver an adequate dose to the CTV. Tar-
get position error covered by the PTV-margin at
irradiation is classified as a set-up error that arises
during patient positioning, and an organ motion er-
ror due to the IM of organs including the target. It
is further classified as an inter-fractional error that
arises between every irradiation, and as an intra-
fractional error that arises during each irradiation.
The PTV-margin must be calculated using actual
error data from patients in each institution. First, the
systematic error that is a mean value of deviations
in the target position, and a random error that is
standard deviation of the deviations in the target
position, must be calculated as shown in the Figure
7. Next, the standard deviation of the systematic
error (Σ) and the square root of the square of the
mean of the random error (σ) is calculated by group
analysis of all patient data. The PTV-margin is deter-
mined using an equation such as 2.5Σ+0.7σ as ad-
vocated by van Herk et al. (7) using values of Σ and
σ calculated for each set-up error and organ motion
error, and for inter-fractional and intra-fractional.
The PTV-margin significantly influences the final
target volume. For example, an increase in the di-
ameter by 1 mm results in a 10% increase in volume
according to mathematical calculation, assuming that
the target is a complete sphere with a diameter of
6 cm. If the PTV becomes larger and the radiation
dose to the surrounding normal tissue becomes
higher, the therapeutic ratio decreases accordingly.
The purpose of IGRT is to make the PTV-margin
as small as possible by improving the accuracy of
positioning. The concrete workflow of IGRT is as
follows. Data on the target position and bony struc-
ture is obtained using an X-ray fluoroscopy device
Figure 7. Analyses of target position errors
χi : mean value of target position errors in a case of i=systematic error (red point), χ : target position at the time of start of radiation
therapy, χref : target position at the time of radiation therapy planning, Ni : fraction number of radiation therapy in a case of i, σ i :
variation of target position error in a case of i (standard deviation)=random error (yellow ellipse), μ : mean value of systematic error
(green point), N : number of cases, Σ : standard deviation of systematic error (red ellipse), σrms : square root of square mean of ran-
dom error
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or CT scanner set up in the RT room just prior to
patient irradiation. The difference from the anatomi-
cal position derived from the RTPS is then calcu-
lated simultaneously so that the patient position
can be adjusted. The term ‘IGRT’ means not only
a technology used for the reduction of positioning
errors at irradiation, but also includes the accurate
diagnosis of the area of tumor invasion for CTV
delineation and evaluation of the treatment effect
using various kind of imaging modalities. IGRT is
a concept that means improvement in the precision
of RT by the use of imaging technology through all
the steps of RT. There is a new concept of RT tech-
nology using IGRT called adaptive RT (ART). In
general, RT requires several weeks to complete,
and changes in the position, size and shape of the
target and OAR during the treatment period influ-
ence the dose distribution and treatment accuracy.
As shown in Figure 8, the concept of ART involves
endeavoring to perform more accurate and elabo-
rate RT. This is achieved by altering the irradiation
according to the anatomical changes that occur dur-
ing the treatment period, using IGRT technology
and new software that enables deformable registra-
tion. If ART makes it possible to avoid a dose defi-
ciency in the target or dose excess of OAR caused
by anatomical changes during treatment, a decrease
in late radiation morbidity and an improvement in
the tumor control rate will be achieved.
Remote controlled after-loading system
The history of brachytherapy began in 1898 when
Mr. and Mrs. Curie discovered radium. A large
body of RT science was created and matured into
the field of radiation medicine, during the half cen-
tury between the 1910s and the 1950s, and formed
the basis of current brachytherapy. However, ra-
dium disappeared completely from the clinical scene
in the 1990s, because of its long physical half-life of
1602 years, and the risk of a radon gas leak caused
by exposure of the radium to air due to breakage
of its protective platinum covering and seal. A re-
mote controlled after-loading system (RALS) using
cesium, cobalt or iridium was developed as an al-
ternative to radium brachytherapy, and has been
popularized since first reported by Walstam (8) in
1960. The application of brachytherapy has ex-
panded into many organs due to downsizing of the
source used in RALS and the development of ap-
plicators that enable precise delivery of the source
to the tumor. This has resulted in a shortening of
the treatment time, thus relieving the physical bur-
den of treatment on patients. The advantage of neg-
ligible radiation exposure to the medical staff, due
to the replacement of radium sources with RALS
is significant. When RALS first started to be used
in brachytherapy, a potential increase in the inci-
dence of radiation morbidity was a concern, due to
Figure 8. Work flow diagram of CT-guided adaptive radiation therapy
CT : computed tomography, LINAC : linear accelerator
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the significant increase in the dose-rate relative to
radium therapy. However, such apprehension has
been almost swept away due to the progressive ac-
cumulation of positive clinical data. If the insertion
technique of the interstitial applicator is improved,
or the optimization of dose distribution is realized
through IGRT, the future clinical significance of
brachytherapy will be maintained.
ROLE OF RADIATION THERAPY AS A
STANDARD TREATMENT METHOD
RT is a first treatment option in various kinds of
head and neck cancer. Glottis cancer in Clinical
Stage (CS) I or II is one of representatives of dis-
ease treated with definitive RT, and 80 to 90% of
glottis cancer in CS I is cured by RT alone (9). Stan-
dard treatment method for epipharyngeal cancer
is chemoradiation therapy, because most of them
have undifferentiated carcinoma sensitive for RT.
Patients with early stage epipharyngeal cacner
treated with RT showed 80 to 90% of overall survival
(10). Also, RT became one of standard treatment
options for uterine cervical cancer in CS I-IVA, non-
small cell lung cancer (NSCLC) in CS IIIB, esopha-
geal cancer in CS III, prostate cancer in CS I-III, and
malignant lymphoma in CS I or II (11). Since 2008
insurance policies have started to cover IMRT for
brain tumor, head and neck tumor, and prostate
cancer in Japan. In the next few years, IMRT will
spread in treatment for cancer, and it will result in
decrease of risk of late radiation morbidity such as
rectal bleeding after RT for prostate cancer and
xerostomia after RT for head and neck tumor. It is
expected that dose escalation achieved by risk re-
duction of radiation morbidity brings improvement
of tumor control.
High level evidences to demonstrate efficacy of
concurrent chemotherapy to RT for various kinds of
cancer were reported in this decade. For example,
all of five randomized controlled trials of chemora-
diation therapy for uterine cervical cancer reported
30 to 50% of survival improvement by performing
concurrent chemotherapy to RT at the annual meet-
ing of American Society of Clinical Oncology in 1999
(12-16) There is some difficulties in applying the
same regimen to Japanese women because patients’
characteristics and RT methods in those trials were
differ from those in Japan (17). However, chemora-
diation therapy has a potential to improve treatment
results of uterine cervical cancer, if suitable regimen
of concurrent chemotherapy for Japanese women
will be established. Chemoradiation therapy has also
become standard treatment option for locally ad-
vanced esophageal cancer of medically operable
patients after Cooper et al. (18) reported its efficacy
in 1999.
Radiation therapy as an alternative to surgery
STI initiated by Leksell (19) in 1951 spreads rap-
idly after insurance policies started to cover in Japan,
and it became a standard treatment method for me-
tastatic brain tumor less than 4 and less than 3 cm
in maximum diameter instead of surgery. Local con-
trol rate of STI for metastatic brain tumor is over
than 85% (20) regardless of radiation sensitivity of
primary lesion. Coverage by insurance policies for
STI was expanded to lung and liver tumor in 2004.
Local control rate of 257 patients with NSCLC in
Stage I reported by Japanese institutes was 86% (21)
at a median follow-up period of 38 months, and no
serious radiation morbidity developed in those pa-
tients. There are video-assisted thoracic surgery and
radiofrequency wave ablation as treatment methods
conflict with STI, but STI is superior to the others
at a point of view of low invasiveness. STI can be-
come an alternative treatment method to surgery
even if for medically operable NSCLC in Stage I,
depending on the clinical results from now.
Iodine-125 permanent implant therapy began in
2003 as a new treatment method of brachytherapy
for low risk prostate cancer instead of surgery. Num-
ber of patients treated with Iodine-125 permanent
implant increases rapidly, because it shows high
tumor control rate same as the radical prostatec-
tomy and lower invasiveness.
Radiation therapy in palliative care
RT plays an important role in palliative care for
cancer with consistently high efficacy in the relief
and control of bone pain, neurological symptom, ob-
structive symptoms, and tumor hemorrhage. Over
than 80% of patients who developed bone metastasis
and superior vena cava syndrome obtained symp-
tom relief by RT (22, 23). Low irradiation dose and
short treatment period of palliative RT can minimize
somatic burden of the patients resulting from treat-
ment, and palliative RT is applicable to the patient
even in poor general condition.
Malignant spinal cord compression syndrome
occurring in 5% (24) of cancer patients causes spi-
nal paraplegia. A prompt and appropriate treat-
ment strategy decision is required for this disorder
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deteriorating quality of life of the patient with lim-
ited prognosis. The most important factor predicting
functional prognosis is the level of neurological defi-
cits at the time of start of RT, and RT must be deliv-
ered before patient becomes non-ambulant. If the
patient falls into paraplegia, walk function recovery
rate becomes only 0 to 30% (25-32). RT is indispen-
sable treatment for these cancer-related clinical dis-
orders described as oncologic emergency.
CONCLUSIONS
The field of RT has entered a period of signifi-
cant change. A rapid increase in the number of pa-
tients undergoing RT and an improvement in the
social recognition of RT are supported by a funda-
mental anti-cancer law announced in 2004, by RT
restructuring and by the basic postural establish-
ment of evidence-based medicine. However, the
proportion of patients who undergo RT in Japan is
limited to approximately 25% of all cancer cases, as
compared with 60% of all cancer cases in Europe
and America. We cannot say that the appropriate
decision on the application of RT is always made in
medical care for cancer patients in Japan. The new
high-precision RT techniques reported in the pre-
sent paper are enabling the expansion of RT appli-
cations to more diseases. However, achieving a high
technical level based on the quality assurance of
machines is indispensable to fully utilize the power
of these high technology devices. Unfortunately, in
Japan, there is a shortage of medical staff who are
specialized in and can maintain a satisfactory tech-
nical level in RT. Indeed, increasing the numbers
of highly specialized RT medical staff, including ra-
diation oncologists, radiation therapists, RT nurses
and medical physicists is essential to Japanese RT
as it enters this new era.
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